2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: comments from the Dutch ACS working group
P Damman, A W van 't Hof, J M Ten Berg, J W Jukema, Y Appelman, A H Liem, R J de Winter, P Damman, A W van 't Hof, J M Ten Berg, J W Jukema, Y Appelman, A H Liem, R J de Winter
Abstract
On behalf of the Dutch ACS working group, we discuss multiple recommendations which have been implemented in the 2015 ESC guidelines for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation.
Keywords: NSTE-ACS guidelines; NVVC ACS working group statement.
Conflict of interest statement
P. Damman, A.W. van ’t Hof, J.M. ten Berg, J.W. Jukema, Y. Appelman, A.H. Liem and R.J. de Winter declare that they have no competing interests.
Figures
References
- Roffi M, Patrono C, Collet JP, et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) Eur Heart J. 2016;37:267–315. doi: 10.1093/eurheartj/ehv320.
- Mueller C. Biomarkers and acute coronary syndromes: an update. Eur Heart J. 2014;35:552–556. doi: 10.1093/eurheartj/eht530.
- Hamm CW, Bassand JP, Agewall S, et al. ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J. 2011;32:2999–3054. doi: 10.1093/eurheartj/ehr236.
- ACCOAST Investigators. Montalescot G, Bolognese L, Dudek D, et al. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med. 2013;369:999–1010. doi: 10.1056/NEJMoa1308075.
- Hansen ML, Sørensen R, Clausen MT, et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med. 2010;170:1433–1441. doi: 10.1001/archinternmed.2010.271.
- WOEST study investigators. Dewilde WJ, Oirbans T, Verheugt FW, et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013;381:1107–1115. doi: 10.1016/S0140-6736(12)62177-1.
- Katritsis DG, Siontis GC, Kastrati A, et al. Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes. Eur Heart J. 2011;32:32–40. doi: 10.1093/eurheartj/ehq276.
- Navarese EP, Gurbel PA, Andreotti F, et al. Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis. Ann Intern Med. 2013;158:261–270. doi: 10.7326/0003-4819-158-4-201302190-00006.
- TIMACS Investigators. Mehta SR, Granger CB, Boden WE, et al. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009;360:2165–2175. doi: 10.1056/NEJMoa0807986.
- Damman P, Hirsch A, Windhausen F, Tijssen JG, de Winter RJ, ICTUS Investigators 5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol. 2010;55:858–864. doi: 10.1016/j.jacc.2009.11.026.
Source: PubMed